πŸ‡ΊπŸ‡Έ FDA
Patent

US 10166277

Vault immunotherapy

granted A61KA61K2039/55516A61K2039/57

Quick answer

US patent 10166277 (Vault immunotherapy) held by THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Grant date
Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K2039/55516, A61K2039/57, A61K2039/572, A61K2039/575